{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:24:09Z","timestamp":1792679049705,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18dm0207018, JP19dm0207072, JP18dk0207026, JP19dk0207049, JP24wm0625304"],"award-info":[{"award-number":["JP18dm0207018, JP19dm0207072, JP18dk0207026, JP19dk0207049, JP24wm0625304"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02998"],"award-info":[{"award-number":["22H02998"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pick\u2019s disease (PiD) is classified as frontotemporal lobar degeneration with pathological tau aggregates. Positron emission tomography (PET) with <jats:sup>18<\/jats:sup>F-florzolotau provides high-contrast imaging of diverse tau fibrils. While our previous work demonstrated the detectability of three repeat (3R) tau pathology by <jats:sup>18<\/jats:sup>F-florzolotau PET in an autopsy-confirmed PiD patient, its potential for quantitative assessment of 3R tau aggregates in living individuals remains unclear. In this study, we analyzed correlations between in vivo <jats:sup>18<\/jats:sup>F-florzolotau retentions and postmortem neuropathological data across brain regions in the same case with PiD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>The patient was 60 years of age at the time of death and had been diagnosed with behavioral variant frontotemporal dementia. The patient underwent <jats:sup>18<\/jats:sup>F-florzolotau PET one year prior to death and was given the pathological diagnosis of PiD by brain autopsy. Regional tau pathology was assessed using Bodian\u2019s silver staining and immunohistochemistry with a monoclonal antibody (AT8). Histopathological assays revealed abundant intraneuronal Pick bodies along with neuropil threads in frontotemporal and other brain areas. In the cerebral cortex, AT8-positive areas exhibited a significant positive correlation with <jats:sup>18<\/jats:sup>F-florzolotau binding in the corresponding regions (Pearson\u2019s <jats:italic>r<\/jats:italic>\u2009=\u20090.81, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) estimated as standardized uptake value ratio corrected for partial volume effect. In contrast, no such associations were found in subcortical structures. Furthermore, a substantial proportion of Pick bodies displayed fluorescence co-labelled with florzolotau and AT8 antibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Collectively, the present findings support the capability of <jats:sup>18<\/jats:sup>F-florzolotau PET for the in vivo quantification of 3R tau fibrils.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13550-025-01296-6","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T17:49:03Z","timestamp":1753984143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuropathological correlations of 18F-florzolotau PET in a case with Pick\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Hisaomi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-1845","authenticated-orcid":false,"given":"Manabu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumoto","family":"Onaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ohgidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"1296_CR1","first-page":"165","volume":"17","author":"P.A Pick","year":"1892","unstructured":"Pick P A. \u00dcber die beziehungen der senilen hirnatrophie Zur aphasie. Prager Medizinische Wochenschrift. 1892;17:165\u20137.","journal-title":"Prager Medizinische Wochenschrift"},{"key":"1296_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","volume":"24","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD, Miller BL. Frontotemporal Lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24:375\u201398. https:\/\/doi.org\/10.2165\/11533100-000000000-00000.","journal-title":"CNS Drugs"},{"key":"1296_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/WCO.0b013e3283168e2d","volume":"21","author":"WW Seeley","year":"2008","unstructured":"Seeley WW. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr Opin Neurol. 2008;21:701\u20137. https:\/\/doi.org\/10.1097\/WCO.0b013e3283168e2d.","journal-title":"Curr Opin Neurol"},{"key":"1296_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137\u201353. https:\/\/doi.org\/10.1007\/s00401-011-0839-6.","journal-title":"Acta Neuropathol"},{"key":"1296_CR5","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/WAD.0b013e31815bf454","volume":"21","author":"BF Boeve","year":"2007","unstructured":"Boeve BF. Links between frontotemporal Lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord. 2007;21:S31\u20138. https:\/\/doi.org\/10.1097\/WAD.0b013e31815bf454.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1296_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, et al. High-Contrast in vivo imaging of Tau pathologies in alzheimer\u2019s and Non-Alzheimer\u2019s disease tauopathies. Neuron. 2021;109:42\u2013e588. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.042.","journal-title":"Neuron"},{"key":"1296_CR7","doi-asserted-by":"publisher","first-page":"fcae075","DOI":"10.1093\/braincomms\/fcae075","volume":"6","author":"M Kubota","year":"2024","unstructured":"Kubota M, Endo H, Takahata K, Tagai K, Suzuki H, Onaya M, et al. In vivo PET classification of Tau pathologies in patients with frontotemporal dementia. Brain Commun. 2024;6:fcae075. https:\/\/doi.org\/10.1093\/braincomms\/fcae075.","journal-title":"Brain Commun"},{"key":"1296_CR8","first-page":"20","volume":"4","author":"Y Imai","year":"1994","unstructured":"Imai Y, Hasegawa K. The revised hasegawa\u2019s dementia scale (HDS-R) \u2014 evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatrists. 1994;4:20\u20134.","journal-title":"J Hong Kong Coll Psychiatrists"},{"key":"1296_CR9","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377. https:\/\/doi.org\/10.1093\/brain\/awr179.","journal-title":"Brain"},{"key":"1296_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0165-1781(02)00094-x","volume":"110","author":"K Shigenobu","year":"2002","unstructured":"Shigenobu K, Ikeda M, Fukuhara R, Maki N, Hokoishi K, Nebu A, et al. The stereotypy rating inventory for frontotemporal Lobar degeneration. Psychiatry Res. 2002;110:175\u201387. https:\/\/doi.org\/10.1016\/s0165-1781(02)00094-x.","journal-title":"Psychiatry Res"},{"key":"1296_CR11","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of alzheimer\u2019s disease enabled by positron emission tomography. J Neurosci. 2007;27:10957\u201368. https:\/\/doi.org\/10.1523\/JNEUROSCI.0673-07.2007.","journal-title":"J Neurosci"},{"key":"1296_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jlcr.3890","volume":"64","author":"K Kawamura","year":"2021","unstructured":"Kawamura K, Hashimoto H, Furutsuka K, Ohkubo T, Fujishiro T, Togashi T, et al. Radiosynthesis and quality control testing of the Tau imaging positron emission tomography tracer [18F]PM-PBB3 for clinical applications. J Label Comp Radiopharm. 2021;64:109\u201319. https:\/\/doi.org\/10.1002\/jlcr.3890.","journal-title":"J Label Comp Radiopharm"},{"key":"1296_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein A, Tourville J. 101 labeled brain images and a consistent human cortical labeling protocol. Front Neurosci. 2012;6:171. https:\/\/doi.org\/10.3389\/fnins.2012.00171.","journal-title":"Front Neurosci"},{"key":"1296_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0896-6273(02)00569-x","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355. https:\/\/doi.org\/10.1016\/s0896-6273(02)00569-x.","journal-title":"Neuron"},{"key":"1296_CR15","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/cercor\/bhm225","volume":"18","author":"B Fischl","year":"2008","unstructured":"Fischl B, Rajendran N, Busa E, Augustinack J, Hinds O, Yeo BT, et al. Cortical folding patterns and predicting cytoarchitecture. Cereb Cortex. 2008;18:1973\u201380. https:\/\/doi.org\/10.1093\/cercor\/bhm225.","journal-title":"Cereb Cortex"},{"key":"1296_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.neuroimage.2007.10.033","volume":"39","author":"OP Hinds","year":"2008","unstructured":"Hinds OP, Rajendran N, Polimeni JR, Augustinack JC, Wiggins G, Wald LL, et al. Accurate prediction of V1 location from cortical folds in a surface coordinate system. NeuroImage. 2008;39:1585\u201399. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.10.033.","journal-title":"NeuroImage"},{"key":"1296_CR17","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904\u201311.","journal-title":"J Nucl Med"},{"key":"1296_CR18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00259-016-3591-2","volume":"44","author":"T Yamane","year":"2017","unstructured":"Yamane T, Ishii K, Sakata M, Ikari Y, Nishio T, Ishii K, et al. Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11\u00a0C-PiB PET amyloid images of the Japanese alzheimer\u2019s disease neuroimaging initiative (J-ADNI) multicenter study. Eur J Nucl Med Mol Imaging. 2017;44:850\u20137. https:\/\/doi.org\/10.1007\/s00259-016-3591-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1296_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, et al. Relationship of phosphorylated alpha-synuclein and Tau accumulation to Abeta deposition in the cerebral cortex of dementia with lewy bodies. Exp Neurol. 2008;210:409\u201320. https:\/\/doi.org\/10.1016\/j.expneurol.2007.11.019.","journal-title":"Exp Neurol"},{"key":"1296_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, et al. Deep clinical and neuropathological phenotyping of pick disease. Ann Neurol. 2016;79:272\u201387. https:\/\/doi.org\/10.1002\/ana.24559.","journal-title":"Ann Neurol"},{"key":"1296_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/brain\/aww339","volume":"140","author":"M Ono","year":"2017","unstructured":"Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, et al. Distinct binding of PET ligands PBB3 and AV-1451 to Tau fibril strains in neurodegenerative Tauopathies. Brain. 2017;140:764\u201380. https:\/\/doi.org\/10.1093\/brain\/aww339.","journal-title":"Brain"},{"key":"1296_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019;24:1112\u201334. https:\/\/doi.org\/10.1038\/s41380-018-0342-8.","journal-title":"Mol Psychiatry"},{"key":"1296_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R, et al. Autoradiography validation of novel Tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7:37. https:\/\/doi.org\/10.1186\/s40478-019-0686-6.","journal-title":"Acta Neuropathol Commun"},{"key":"1296_CR24","doi-asserted-by":"publisher","first-page":"e0284182","DOI":"10.1371\/journal.pone.0284182","volume":"18","author":"RG Gatto","year":"2023","unstructured":"Gatto RG, Carlos AF, Reichard RR, Lowe VJ, Whitwell JL, Josephs KA. Comparative assessment of regional Tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of alzheimer\u2019s & frontotemporal Lobar degeneration patients. PLoS ONE. 2023;18:e0284182. https:\/\/doi.org\/10.1371\/journal.pone.0284182.","journal-title":"PLoS ONE"},{"key":"1296_CR25","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41380-022-01875-2","volume":"28","author":"ML Malarte","year":"2023","unstructured":"Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A. Discriminative binding of Tau PET tracers PI2620, MK6240 and RO948 in alzheimer\u2019s disease, corticobasal degeneration and progressive supranuclear palsy brains. Mol Psychiatry. 2023;28:1272\u201383. https:\/\/doi.org\/10.1038\/s41380-022-01875-2.","journal-title":"Mol Psychiatry"},{"key":"1296_CR26","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2967\/jnumed.121.263196","volume":"63","author":"C Groot","year":"2022","unstructured":"Groot C, Villeneuve S, Smith R, Hansson O, Ossenkoppele R. Tau PET imaging in neurodegenerative disorders. J Nucl Med. 2022;63:S20\u20136. https:\/\/doi.org\/10.2967\/jnumed.121.263196.","journal-title":"J Nucl Med"},{"key":"1296_CR27","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/alz.12975","volume":"19","author":"V Planche","year":"2023","unstructured":"Planche V, Mansencal B, Manjon JV, Tourdias T, Catheline G, Coupe P, et al. Anatomical MRI staging of frontotemporal dementia variants. Alzheimers Dement. 2023;19:3283\u201394. https:\/\/doi.org\/10.1002\/alz.12975.","journal-title":"Alzheimers Dement"},{"key":"1296_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41421-024-00674-z","volume":"10","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Fan Y, Zhao W, Ni Y, Tao Y, Bian J, et al. A Tau PET tracer PBB3 binds to TMEM106B amyloid fibril in brain. Cell Discov. 2024;10:50. https:\/\/doi.org\/10.1038\/s41421-024-00674-z.","journal-title":"Cell Discov"},{"key":"1296_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","volume":"76","author":"R Smith","year":"2019","unstructured":"Smith R, Wibom M, Pawlik D, Englund E, Hansson O. Correlation of in vivo [18F]Flortaucipir with postmortem alzheimer disease Tau pathology. JAMA Neurol. 2019;76:310\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3692.","journal-title":"JAMA Neurol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01296-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01296-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01296-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T13:42:20Z","timestamp":1755783740000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01296-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1296"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01296-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Radiation Drug Safety Committee and the Institutional Review Board of the National Institutes for Quantum Science and Technology, Japan, and the Institutional Ethical Review Board of the Shimofusa Psychiatric Medical Center, Japan. This study was conducted in accordance with the Code of Ethics of the World Medical Association. After a complete description of the study, written informed consent was obtained from the patient\u2019s legal representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the legal representative of the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest regarding financial support or relationships.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}